{"id":12784,"date":"2026-02-18T13:51:00","date_gmt":"2026-02-18T13:51:00","guid":{"rendered":"https:\/\/csiag.de\/?p=12784"},"modified":"2026-04-05T15:41:39","modified_gmt":"2026-04-05T15:41:39","slug":"fotobiomodulacio-pbm","status":"publish","type":"post","link":"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/","title":{"rendered":"Fotobiomodul\u00e1ci\u00f3 (PBM)"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Tartalomjegyz\u00e9k<\/p>\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Einleitung\" >Bevezet\u00e9s<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Indikationen_auf_einen_Blick\" >Jelz\u00e9sek \u00e1ttekint\u00e9se<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Haut_Wundheilung_Kollagen_660_nm\" >B\u0151r, sebgy\u00f3gyul\u00e1s \u00e9s kollag\u00e9n (660 nm)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Ubergreifende_Reviews_Mechanismen\" >\u00c1tfog\u00f3 fel\u00fclvizsg\u00e1latok \u00e9s mechanizmusok<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kollagensynthese_Hautverjungung\" >Kollag\u00e9nszint\u00e9zis \u00e9s b\u0151rfiatal\u00edt\u00e1s<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Klinische_Studien_Wundheilung_JAAD\" >Klinikai tanulm\u00e1nyok Sebgy\u00f3gyul\u00e1s (JAAD)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Muskeln_Sport_Rehabilitation_850_nm\" >Izmok, sport \u00e9s rehabilit\u00e1ci\u00f3 (850 nm)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Skelettmuskelregeneration\" >V\u00e1zizomzat regener\u00e1ci\u00f3ja<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Meta-Analysen_Sportleistung_Muskelkater\" >A sportteljes\u00edtm\u00e9ny \u00e9s az izomf\u00e1jdalom metaanal\u00edzisei<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Gehirn_Kognition_Neurologie_810%E2%80%931064_nm\" >Agy, megismer\u00e9s \u00e9s neurol\u00f3gia (810-1,064 nm)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Mechanismen_allgemeine_Wirkungen\" >Mechanizmusok \u00e9s \u00e1ltal\u00e1nos hat\u00e1sok<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Alzheimer_Demenz\" >Alzheimer-k\u00f3r \u00e9s demencia<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#TBI_Entgiftung_1064_nm\" >TBI \u00e9s m\u00e9regtelen\u00edt\u00e9s (1,064 nm)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Schmerzmanagement\" >F\u00e1jdalomcsillap\u00edt\u00e1s<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Ubergreifende_Reviews\" >\u00c1tfog\u00f3 fel\u00fclvizsg\u00e1latok<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Fibromyalgie\" >Fibromyalgia<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kniearthrose_Tendinopathie\" >T\u00e9rd\u00edz\u00fcleti csontritisz \u00e9s \u00ednh\u00fcvelygyullad\u00e1s<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Neuropathischer_Schmerz\" >Neurop\u00e1ti\u00e1s f\u00e1jdalom<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Augenheilkunde_AMD\" >Szem\u00e9szet (AMD)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Altersbedingte_Makuladegeneration\" >Id\u0151skori makuladegener\u00e1ci\u00f3<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Onkologie_Mukositis\" >Onkol\u00f3gia \u00e9s ny\u00e1lkah\u00e1rtya-gyullad\u00e1s<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Leitlinien\" >Ir\u00e1nyelvek<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Chemotherapie-induzierte_Mukositis\" >Kemoter\u00e1pia okozta mucositis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kopf-Hals-Karzinome_Strahlentherapie\" >Fej-nyaki r\u00e1k \u00e9s sug\u00e1rter\u00e1pia<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Immunsystem_Entzundung\" >Immunrendszer \u00e9s gyullad\u00e1s<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Immunmodulation\" >Immunmodul\u00e1ci\u00f3<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Klinische_Empfehlungen\" >Klinikai aj\u00e1nl\u00e1sok<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Allgemeine_Dosierungsregeln_Konsensus\" >\u00c1ltal\u00e1nos adagol\u00e1si szab\u00e1lyok (konszenzus)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Evidenzstarke_nach_Bereich\" >A bizony\u00edt\u00e9kok er\u0151ss\u00e9ge ter\u00fcletenk\u00e9nt<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kontakt_zu_PBM-Anwendern_%E2%80%93_Arzte_Kliniken\" >Kapcsolat a PBM felhaszn\u00e1l\u00f3kkal - orvosok \/ klinik\u00e1k<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Augenheilkunde_%E2%80%93_Trockene_AMD_Makuladegeneration\" >Szem\u00e9szet - Sz\u00e1raz AMD (makula degener\u00e1ci\u00f3)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Onkologie_%E2%80%93_Orale_Mukositis_Chemo-Strahlentherapiefolge\" >Onkol\u00f3gia - Sz\u00e1jny\u00e1lkah\u00e1rtya-gyullad\u00e1s (kemoter\u00e1pia\/sug\u00e1rter\u00e1pia k\u00f6vetkezm\u00e9nye)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Dermatologie_%E2%80%93_Haut_Wundheilung_Akne_Psoriasis\" >B\u0151rgy\u00f3gy\u00e1szat - b\u0151r, sebgy\u00f3gyul\u00e1s, akne, pikkelys\u00f6m\u00f6r<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Zahnmedizin_MKG-Chirurgie\" >Fog\u00e1szat \/ \u00e1llcsont- \u00e9s arcseb\u00e9szet<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-35\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Neurologie_Psychiatrie_%E2%80%93_Alzheimer_TBI_Depression_fruhe_Phase\" >Neurol\u00f3gia \/ Pszichi\u00e1tria - Alzheimer-k\u00f3r, TBI, depresszi\u00f3 (korai f\u00e1zis)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-36\" href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Allgemeine_Suchwerkzeuge\" >\u00c1ltal\u00e1nos keres\u0151eszk\u00f6z\u00f6k<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Olvas\u00e1si id\u0151<\/span> <span class=\"rt-time\"> 12<\/span> <span class=\"rt-label rt-postfix\">percek<\/span><\/span>\n<p>\u00c1tfog\u00f3 tanulm\u00e1nyi \u00e1ttekint\u00e9s 2023-2025<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Einleitung\"><\/span>Bevezet\u00e9s<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A fotobiomodul\u00e1ci\u00f3 (PBM), m\u00e1s n\u00e9ven alacsony szint\u0171 l\u00e9zerter\u00e1pia (LLLT) egy nem invaz\u00edv ter\u00e1pi\u00e1s m\u00f3dszer, amely meghat\u00e1rozott hull\u00e1mhossz\u00fas\u00e1g\u00fa f\u00e9nyt haszn\u00e1l az \u00e9l\u0151 sz\u00f6vetekben zajl\u00f3 biol\u00f3giai folyamatok stimul\u00e1l\u00e1s\u00e1ra.<br>Az els\u0151dleges mechanizmus a fotonok elnyel\u00e9se a mitokondri\u00e1lis fotoakceptor \u00e1ltal. <em>Citokr\u00f3m c oxid\u00e1z<\/em> (CCO), amely a <em>ATP szint\u00e9zis<\/em> modul\u00e1lja a reakt\u00edv oxig\u00e9nfajokat, \u00e9s a sejtregener\u00e1ci\u00f3s folyamatok kaszk\u00e1dj\u00e1t ind\u00edtja el.<\/p>\n\n\n\n<p>A ter\u00e1pi\u00e1s szempontb\u00f3l relev\u00e1ns \u201eoptikai ablak\u201c 600 \u00e9s 1100 nm k\u00f6z\u00f6tt van. H\u00e1rom klinikailag k\u00fcl\u00f6n\u00f6sen fontos hull\u00e1mhossz:<\/p>\n\n\n\n<p><strong>660 nm<\/strong><br>Behatol\u00e1si m\u00e9lys\u00e9g 1-10 mm, teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g 6-50 mW\/cm\u00b2<br>Ide\u00e1lis b\u0151rre, sebgy\u00f3gyul\u00e1sra \u00e9s fel\u00fcletes sz\u00f6vetekre.<\/p>\n\n\n\n<p><strong>850 nm<\/strong><br>Behatol\u00e1si m\u00e9lys\u00e9g ak\u00e1r 50 mm, teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g 50-100 mW\/cm\u00b2<br>Alkalmas az izmok, \u00edz\u00fcletek \u00e9s m\u00e9lyebb strukt\u00far\u00e1k sz\u00e1m\u00e1ra.<\/p>\n\n\n\n<p><strong>1,050-1,064 nm<\/strong><br>M\u00e9ly sz\u00f6veti behatol\u00e1s, teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g 25-285 mW\/cm\u00b2 (transzkrani\u00e1lis)<br>A neurol\u00f3gia, az agy \u00e9s a szem\u00e9szet szempontj\u00e1b\u00f3l relev\u00e1ns.<\/p>\n\n\n\n<p>A d\u00f3zis meghat\u00e1roz\u00e1s\u00e1nak alapelve a k\u00f6vetkez\u0151 <em>Arndt-Schulz-g\u00f6rbe<\/em> (Horm\u00e9zis):<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A t\u00fal kev\u00e9s f\u00e9nynek nincs hat\u00e1sa, az optim\u00e1lis d\u00f3zis serkenti a<\/li>\n\n\n\n<li>A t\u00fal soknak g\u00e1tl\u00f3 vagy sejtk\u00e1ros\u00edt\u00f3 hat\u00e1sa van.<\/li>\n<\/ul>\n\n\n\n<p>Ez a k\u00e9tf\u00e1zis\u00fa kapcsolat magyar\u00e1zza, hogy a helyes teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g \u00e9s energias\u0171r\u0171s\u00e9g mi\u00e9rt kulcsfontoss\u00e1g\u00fa a sikeres ter\u00e1pia szempontj\u00e1b\u00f3l.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Indikationen_auf_einen_Blick\"><\/span>Jelz\u00e9sek \u00e1ttekint\u00e9se<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A k\u00f6vetkez\u0151 t\u00e1bl\u00e1zat \u00f6sszefoglalja a klinikai vizsg\u00e1latokban haszn\u00e1lt param\u00e9tereket (hull\u00e1mhossz, teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g, energias\u0171r\u0171s\u00e9g, id\u0151tartam, frekvencia) az egyes kezel\u00e9si ter\u00fcletek eset\u00e9ben. <br>Forr\u00e1sok: Hamblin\/Harvard (<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8355782\/\" target=\"_blank\" rel=\"noreferrer noopener\">PMC8355782<\/a>), <a href=\"https:\/\/waltpbm.org\/\" target=\"_blank\" rel=\"noopener\">WALT-ir\u00e1nyelvek<\/a>, klinikai vizsg\u00e1latok 2020-2025.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Jelz\u00e9s<\/strong><\/td><td><strong>Hull\u00e1mhossz<\/strong><\/td><td><strong>Teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g<\/strong><\/td><td><strong>Energias\u0171r\u0171s\u00e9g<\/strong><\/td><td><strong>Id\u0151tartam \/ munkamenet<\/strong><\/td><td><strong>Frekvencia<\/strong><\/td><\/tr><\/thead><tbody><tr><td>B\u0151r \/ Kollag\u00e9n<\/td><td>660 nm<\/td><td>6-50 mW\/cm\u00b2<\/td><td>8-16 J\/cm\u00b2<\/td><td>10-21 perc<\/td><td>2-3\u00d7 \/ h\u00e9t<\/td><\/tr><tr><td>Sebgy\u00f3gyul\u00e1s<\/td><td>630-660 nm<\/td><td>10-50 mW\/cm\u00b2<\/td><td>4-15 J\/cm\u00b2<\/td><td>7-20 perc<\/td><td>naponta - 3\u00d7 \/ h\u00e9t<\/td><\/tr><tr><td>Izomregener\u00e1ci\u00f3<\/td><td>808-850 nm<\/td><td>50-100 mW\/cm\u00b2<\/td><td>10-30 J\/cm\u00b2<\/td><td>5-15 perc<\/td><td>k\u00f6zvetlen\u00fcl sportol\u00e1s el\u0151tt\/ut\u00e1n<\/td><\/tr><tr><td>Kr\u00f3nikus f\u00e1jdalom<\/td><td>630-905 nm<\/td><td>40-100 mW\/cm\u00b2<\/td><td>4-10 J\/cm\u00b2<\/td><td>10-20 perc<\/td><td>3\u00d7 \/ h\u00e9t, 6-12 h\u00e9t.<\/td><\/tr><tr><td>Fibromyalgia<\/td><td>630-1,100 nm (eg\u00e9sz test)<\/td><td>v\u00e1ltoz\u00f3<\/td><td>1-150 J\/cm\u00b2<\/td><td>15-30 perc<\/td><td>2-3\u00d7 \/ h\u00e9t, 4-6 h\u00e9t.<\/td><\/tr><tr><td>T\u00e9rd\u00edz\u00fcleti arthrosis<\/td><td>630-850 nm<\/td><td>40-80 mW\/cm\u00b2<\/td><td>4-10 J\/cm\u00b2<\/td><td>10-20 perc<\/td><td>3\u00d7 \/ h\u00e9t<\/td><\/tr><tr><td>Agy \/ megismer\u00e9s<\/td><td>810-1,064 nm (transzkrani\u00e1lis)<\/td><td>25-285 mW\/cm\u00b2<\/td><td>20-60 J\/cm\u00b2<\/td><td>10-20 perc<\/td><td>3\u00d7 \/ h\u00e9t<\/td><\/tr><tr><td>AMD \/ szem<\/td><td>590 + 660 + 850 nm<\/td><td>0,3-15 \u03bcW\/cm\u00b2 (retina)<\/td><td>Nagyon alacsony<\/td><td>3-10 perc \/ \u00fcl\u00e9s<\/td><td>3\u00d7\/h\u00e9t naponta<\/td><\/tr><tr><td>Mucositis (onkol\u00f3gia)<\/td><td>630-660 nm<\/td><td>10-25 mW\/cm\u00b2<\/td><td>2-6 J\/cm\u00b2<\/td><td>3-5 perc \/ pont<\/td><td>naponta a ter\u00e1pia alatt<\/td><\/tr><tr><td>Immunmodul\u00e1ci\u00f3 \/ gyullad\u00e1s<\/td><td>650-950 nm<\/td><td>v\u00e1ltoz\u00f3<\/td><td>1-10 J\/cm\u00b2<\/td><td>5-15 perc<\/td><td>3\u00d7 \/ h\u00e9t<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><em>Teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g = Sug\u00e1rz\u00e1si s\u0171r\u0171s\u00e9g (mW\/cm\u00b2) a sz\u00f6vet felsz\u00edn\u00e9n.<\/em><br><em>Energias\u0171r\u0171s\u00e9g = fluencia (J\/cm\u00b2) \u00fcl\u00e9senk\u00e9nt.<\/em><br><em>AMD: A retina besug\u00e1rz\u00e1si \u00e9rt\u00e9kei jelent\u0151sen alacsonyabbak, mint a b\u0151rfel\u00fcleti \u00e9rt\u00e9kek.<\/em><br><em><strong>Hint<\/strong>Nincs egys\u00e9ges nemzetk\u00f6zi szabv\u00e1ny - az \u00e9rt\u00e9kek a metaanal\u00edzisek \u00e9s a WALT aj\u00e1nl\u00e1sok konszenzus\u00e1t t\u00fckr\u00f6zik.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Haut_Wundheilung_Kollagen_660_nm\"><\/span>B\u0151r, sebgy\u00f3gyul\u00e1s \u00e9s kollag\u00e9n (660 nm)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A 660 nm-es v\u00f6r\u00f6s f\u00e9nyt a b\u0151r kromof\u00f3rjai k\u00fcl\u00f6n\u00f6sen hat\u00e9konyan elnyelik, \u00e9s a COL1A1 \u00e9s COL3A1 g\u00e9nexpresszi\u00f3, valamint az MMP-9 \u00e9s az NO felszabadul\u00e1sa r\u00e9v\u00e9n aktiv\u00e1lja a kollag\u00e9nszint\u00e9zist a fibroblasztokban. Behatol\u00e1si m\u00e9lys\u00e9g: 1-10 mm (epidermisz, dermisz, hipodermisz). A k\u00e9tf\u00e1zis\u00fa d\u00f3zismint\u00e1zat k\u00fcl\u00f6n\u00f6sen hangs\u00falyos a b\u0151rsz\u00f6vetben: a 20 J\/cm\u00b2 feletti energias\u0171r\u0171s\u00e9g oxidat\u00edv stresszt \u00e9s ford\u00edtott kollag\u00e9nstimul\u00e1ci\u00f3t v\u00e1lthat ki.<\/p>\n\n\n\n<p><strong>Param\u00e9terek<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>hull\u00e1mhossz 660 nm (630-680 nm is)<\/li>\n\n\n\n<li>Teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g 6-50 mW\/cm\u00b2 (LED: 6-30; l\u00e9zer: 30-50)<\/li>\n\n\n\n<li>Energias\u0171r\u0171s\u00e9g 8-16 J\/cm\u00b2 (optim\u00e1lis)<\/li>\n\n\n\n<li>Id\u0151tartam 10-21 perc | 3\u00d7 hetente<\/li>\n\n\n\n<li>Legal\u00e1bb 8 h\u00e9t a b\u0151rfiatal\u00edt\u00e1shoz; 4 h\u00e9t a sebgy\u00f3gyul\u00e1shoz.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ubergreifende_Reviews_Mechanismen\"><\/span>\u00c1tfog\u00f3 fel\u00fclvizsg\u00e1latok \u00e9s mechanizmusok<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>A f\u00e9nyt\u0151l a gy\u00f3gyul\u00e1sig: Fotobiomodul\u00e1ci\u00f3s ter\u00e1pia az orvosi tudom\u00e1ny\u00e1gakban<\/strong><br><em>Journal of Translational Medicine (2025)<\/em><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12751248\/\" target=\"_blank\" rel=\"noopener\"> Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>\u00c1tfog\u00f3 \u00e1ttekint\u00e9s a fotofizika, a mitokondri\u00e1lis biol\u00f3gia \u00e9s a klinikai rehabilit\u00e1ci\u00f3 \u00f6tv\u00f6z\u00e9s\u00e9vel. A 600-1 100 nm-es PBM a CCO-n kereszt\u00fcl fokozott ATP-szint\u00e9zist \u00e9s ellen\u0151rz\u00f6tt ROS-szign\u00e1l\u00e1st aktiv\u00e1l, ami aktiv\u00e1lja a transzkripci\u00f3s faktorokat (NF-\u03baB, AP-1, HIF-1\u03b1) \u00e9s felszab\u00e1lyozza a n\u00f6veked\u00e9si faktorokat (TGF-\u03b2, VEGF, IGF-1). Sz\u00f6veti szinten el\u0151seg\u00edti a fibroblasztok \u00e9s keratinocit\u00e1k prolifer\u00e1ci\u00f3j\u00e1t, a makrof\u00e1gok polariz\u00e1ci\u00f3j\u00e1t \u00e9s a kollag\u00e9nszint\u00e9zist. Legfontosabb d\u00f3zisaj\u00e1nl\u00e1s az alacsony mitokondriumtartalm\u00fa sz\u00f6vetekhez (b\u0151r, \u00edn): Teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g &lt; 100 mW\/cm\u00b2, energias\u0171r\u0171s\u00e9g 4-10 J\/cm\u00b2 a c\u00e9lsz\u00f6vetben.<\/p>\n\n\n\n<p><strong>A f\u00e9ny erej\u00e9nek felszabad\u00edt\u00e1sa a b\u0151r\u00f6n: A fotobiomodul\u00e1ci\u00f3 \u00e1tfog\u00f3 \u00e1ttekint\u00e9se<\/strong><br><em>Int. J. Mol. Sci. (2024)<\/em> <a href=\"https:\/\/www.mdpi.com\/1422-0067\/25\/8\/4483\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>A b\u0151rgy\u00f3gy\u00e1szatban alkalmazott PBM-re vonatkoz\u00f3 klinikai vizsg\u00e1latok narrat\u00edv \u00e1ttekint\u00e9se (6 \u00e9v). A leggyakrabban a 630-950 nm-t haszn\u00e1lt\u00e1k. Optim\u00e1lis b\u0151rfiatal\u00edt\u00e1shoz: 630-660 nm, 6-50 mW\/cm\u00b2, 8-16 J\/cm\u00b2, 3\u00d7\/h\u00e9t. Bikini bif\u00e1zisos hat\u00e1s: Legjobb eredm\u00e9nyek m\u00e9rs\u00e9kelt-k\u00f6zepes d\u00f3zisokkal; a t\u00faladagol\u00e1s (&gt;20 J\/cm\u00b2 a b\u0151rfel\u00fcleten) g\u00e1tolhatja a kollag\u00e9nszint\u00e9zist ahelyett, hogy el\u0151seg\u00edten\u00e9 azt.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kollagensynthese_Hautverjungung\"><\/span>Kollag\u00e9nszint\u00e9zis \u00e9s b\u0151rfiatal\u00edt\u00e1s<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>Az alacsony szint\u0171 f\u00e9nyter\u00e1pia optimaliz\u00e1l\u00e1sa a b\u0151rfiatal\u00edt\u00e1sban<\/strong><br><em>SCIRP (2025)<\/em> <a href=\"https:\/\/www.scirp.org\/journal\/paperinformation?paperid=142513\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>RCT (osztott fel\u00fclet\u0171) 830 nm + 633 nm-es LED-del. Param\u00e9terek: 6,4 mW\/cm\u00b2, 8,05 J\/cm\u00b2, 21 perc kezel\u00e9senk\u00e9nt, 3\u00d7\/h\u00e9t 4 h\u00e9ten kereszt\u00fcl. Jelent\u0151s r\u00e1nctalan\u00edt\u00e1s \u00e9s a b\u0151r rugalmass\u00e1g\u00e1nak jav\u00edt\u00e1sa. Legfontosabb meg\u00e1llap\u00edt\u00e1s: a heti 3 kezel\u00e9s hat\u00e9konyabb volt, mint a 2 - a gyakoris\u00e1g er\u0151sen befoly\u00e1solta az eredm\u00e9nyt.<\/p>\n\n\n\n<p><strong>A b\u0151r kollag\u00e9n anyagcser\u00e9j\u00e9nek szab\u00e1lyoz\u00e1sa 660 nm-es LED seg\u00edts\u00e9g\u00e9vel<\/strong><br><em>Journal of Investigative Dermatology (klasszikus tanulm\u00e1ny)<\/em><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022202X15341749\" target=\"_blank\" rel=\"noopener\"> Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p><strong>Param\u00e9terek<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>660 nm, impulzus (szekvenci\u00e1lis impulzus \u00fczemm\u00f3d\u00fa LED)<\/li>\n\n\n\n<li>11 tal\u00e1lkoz\u00f3<\/li>\n<\/ul>\n\n\n\n<p><strong>Eredm\u00e9nyek<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>+31% 1-es t\u00edpus\u00fa prokollag\u00e9n<\/li>\n\n\n\n<li>-18% MMP-1 sz\u00f6veti biopszi\u00e1kban.<\/li>\n\n\n\n<li>A tesztalanyok &gt;90%-j\u00e9n\u00e9l cs\u00f6kkent a r\u00e1ncok m\u00e9lys\u00e9ge.<\/li>\n\n\n\n<li>A fotobiol\u00f3giai hat\u00e9konys\u00e1g szempontj\u00e1b\u00f3l a szekvenci\u00e1lis impulzusmint\u00e1zat (nem a folyamatos hull\u00e1m) volt a d\u00f6nt\u0151.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Klinische_Studien_Wundheilung_JAAD\"><\/span>Klinikai tanulm\u00e1nyok Sebgy\u00f3gyul\u00e1s (JAAD)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>Fotobiomodul\u00e1ci\u00f3s CME II. r\u00e9sz: Klinikai alkalmaz\u00e1sok a b\u0151rgy\u00f3gy\u00e1szatban<\/strong><br><em>Az Amerikai B\u0151rgy\u00f3gy\u00e1szati Akad\u00e9mia foly\u00f3irata (2024)<\/em> <a href=\"https:\/\/www.jaad.org\/article\/S0190-9622(24)00187-7\/fulltext\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>T\u00f6bb mint 20 szak\u00e9rt\u0151 konszenzusa (JAAD). A diab\u00e9teszes fek\u00e9lyek param\u00e9terei (IA szint\u0171 bizony\u00edt\u00e9k): 630-670 nm, 10-50 mW\/cm\u00b2, 2-6 J\/cm\u00b2, napi alkalmaz\u00e1s vagy 3\u00d7\/h\u00e9t a sebz\u00e1r\u00f3d\u00e1sig. 12 RCT metaanal\u00edzise: fek\u00e9ly ter\u00fclete -30,9%, -4,2 cm\u00b2 a kontrollhoz k\u00e9pest. Minden sebgy\u00f3gyul\u00e1si f\u00e1zis (gyullad\u00e1sos, proliferat\u00edv, remodelling) pozit\u00edvan befoly\u00e1solt.<\/p>\n\n\n\n<p><strong>A PBM ter\u00e1pia (660 nm) hat\u00e1sa a Staphylococcus aureus \u00e1ltal fert\u0151z\u00f6tt sebek gy\u00f3gyul\u00e1s\u00e1ra<\/strong><br><em>Fotobiomodul Photomed Laser Surg. (2020)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32466696\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>\u00c1llatk\u00eds\u00e9rlet: 660 nm, 35 perc\/nap, 7 nap. Jelent\u0151sen kisebb sebek (p &lt; 0,01), t\u00f6bb granul\u00e1ci\u00f3s sz\u00f6vet, legmagasabb kollag\u00e9ntartalom (3+ fokozat). A PCNA prolifer\u00e1ci\u00f3s markerek szignifik\u00e1nsan megn\u00f6vekedtek. Megjegyz\u00e9s: Az intenzit\u00e1st sz\u00e1nd\u00e9kosan alacsonyan tartott\u00e1k - fert\u0151z\u00f6tt sebek eset\u00e9ben k\u00fcl\u00f6n\u00f6sen fontos, hogy ne l\u00e9pj\u00fck t\u00fal a d\u00f3zist (&lt; 15 J\/cm\u00b2).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Muskeln_Sport_Rehabilitation_850_nm\"><\/span>Izmok, sport \u00e9s rehabilit\u00e1ci\u00f3 (850 nm)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A 850 nm-es k\u00f6zeli infrav\u00f6r\u00f6s f\u00e9ny ak\u00e1r 50 mm m\u00e9lyre is behatol. Egy metaanal\u00edzis szerint (Baroni et al., 2019) az izomalkalmaz\u00e1sok optim\u00e1lis param\u00e9tere 810 nm, 100 mW\/cm\u00b2, 30 J\/cm\u00b2 - edzett sportol\u00f3kn\u00e1l 15% er\u0151n\u00f6veked\u00e9st m\u00e9rtek. Ha a d\u00f3zisok t\u00fal magasak (&gt;50 J\/cm\u00b2, &gt;200 mW\/cm\u00b2), a hat\u00e1sok cs\u00f6kkennek. Leal-Junior \u00e9s munkat\u00e1rsai (2011) tanulm\u00e1nya a 810 nm-es sug\u00e1rz\u00e1s optim\u00e1lis d\u00f3zis\u00e1t 30 J \u00f6sszd\u00f3zisban (nem J\/cm\u00b2) hat\u00e1rozta meg 6 izomponton kereszt\u00fcl az edz\u00e9s el\u0151tt.<\/p>\n\n\n\n<p><strong>Param\u00e9terek<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Hull\u00e1mhossz 808-850 nm<\/li>\n\n\n\n<li>Teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g 50-100 mW\/cm\u00b2 (l\u00e9zer); 30-150 mW\/cm\u00b2 (LED panel)<\/li>\n\n\n\n<li>Energias\u0171r\u0171s\u00e9g 10-30 J\/cm\u00b2 (sportol\u00f3k); 6-10 J\/cm\u00b2 (rehabilit\u00e1ci\u00f3)<\/li>\n\n\n\n<li>Id\u0151tartam 5-15 perc\/izomcsoport<br>Haszn\u00e1lja k\u00f6zvetlen\u00fcl edz\u00e9s el\u0151tt vagy ut\u00e1n<\/li>\n\n\n\n<li>3-7\u00d7\/h\u00e9t intenz\u00edv edz\u00e9s eset\u00e9n; 2-3\u00d7 rehabilit\u00e1ci\u00f3 eset\u00e9n<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Skelettmuskelregeneration\"><\/span>V\u00e1zizomzat regener\u00e1ci\u00f3ja<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>PBMT a v\u00e1zizomzat regener\u00e1ci\u00f3j\u00e1ban: \u00e1tfog\u00f3 \u00e1ttekint\u00e9s<\/strong><br><em>Fotodiagnosztika \u00e9s fotodinamikus ter\u00e1pia (2025)<\/em> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1572100025001668\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>Kulcsfontoss\u00e1g\u00fa tanulm\u00e1ny (Baroni 2019): 810 nm, 100 mW\/cm\u00b2, 30 J\/cm\u00b2, 6 izompont \u2192 15% er\u0151n\u00f6veked\u00e9s sportol\u00f3kn\u00e1l. IL-6 cs\u00f6kken\u00e9s 40% \u00e1ltal prevent\u00edv PBM-mel (5 J\/cm\u00b2 patk\u00e1ny tibialis\u00e1n). Figyelmeztet\u00e9s: Az \u00e1llatk\u00eds\u00e9rletekb\u0151l sz\u00e1rmaz\u00f3 param\u00e9terek (pl. 5 J\/cm\u00b2) nem vihet\u0151k \u00e1t k\u00f6zvetlen\u00fcl emberekre - az emberi quadricepsz nagyobb energias\u0171r\u0171s\u00e9get ig\u00e9nyel a nagyobb sz\u00f6veti m\u00e9lys\u00e9g miatt.<\/p>\n\n\n\n<p><strong>PBM az emberi izomsz\u00f6vetben: el\u0151ny a sportteljes\u00edtm\u00e9nyben?<\/strong><br><em>J. Biophotonics (PMC) (2016)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5167494\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>Az \u00f6sszes RCT (1b. szint) \u00e9s esettanulm\u00e1ny (3b. szint) szisztematikus \u00e1ttekint\u00e9se. A leghat\u00e9konyabb param\u00e9terek a bicepsz alkalmaz\u00e1s\u00e1hoz: 810-850 nm, 50-100 mW\/cm\u00b2, 10-30 J\/cm\u00b2. Leghat\u00e9konyabb param\u00e9terek a quadricepszn\u00e9l (nagyobb izom, m\u00e9lyebb sz\u00f6vet): nagyobb energi\u00e1k sz\u00fcks\u00e9gesek, el\u0151nyben r\u00e9szes\u00fclnek a klaszteres applik\u00e1torok (5 di\u00f3da). A PBM edz\u00e9s el\u0151tti alkalmaz\u00e1sa az er\u0151\u00e9rt\u00e9kek tekintet\u00e9ben legal\u00e1bb egyen\u00e9rt\u00e9k\u0171, gyakran jobb, mint az edz\u00e9s ut\u00e1ni alkalmaz\u00e1s.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Meta-Analysen_Sportleistung_Muskelkater\"><\/span>A sportteljes\u00edtm\u00e9ny \u00e9s az izomf\u00e1jdalom metaanal\u00edzisei<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>A DOMS fotomodul\u00e1ci\u00f3s ter\u00e1pia hat\u00e1sa: Rendszeres \u00e1ttekint\u00e9s \u00e9s metaanal\u00edzis<\/strong><br><em>MDPI JFMK (2025)<\/em> <a href=\"https:\/\/www.mdpi.com\/2411-5142\/10\/3\/277\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>14 vizsg\u00e1lat, 660-950 nm hull\u00e1mhossz, 1-6 izompont. Optim\u00e1lis a DOMS cs\u00f6kkent\u00e9s\u00e9re: 830-850 nm, 50-100 mW\/cm\u00b2, 6-10 J\/cm\u00b2 pontonk\u00e9nt, k\u00f6zvetlen\u00fcl edz\u00e9s ut\u00e1n. Jelent\u0151s VAS f\u00e1jdalomcs\u00f6kken\u00e9s a placeb\u00f3hoz k\u00e9pest; pozit\u00edv hat\u00e1s az izomer\u0151 megtart\u00e1s\u00e1ra.<\/p>\n\n\n\n<p><strong>Az edz\u00e9s el\u0151tti PBM jav\u00edthatja az izmok \u00e1ll\u00f3k\u00e9pess\u00e9g\u00e9t \u00e9s el\u0151seg\u00edtheti a regener\u00e1l\u00f3d\u00e1st? Metaanal\u00edzis<\/strong><br><em>L\u00e9zerek az orvostudom\u00e1nyban (2024)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38758297\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>A kreatin-kin\u00e1z 77,56 egys\u00e9ggel cs\u00f6kkent (95%-KI: -112,67-r\u0151l -42,44-re, p &lt; 0,01). Leghat\u00e9konyabb param\u00e9terek: 810 nm, 200 mW \u00f6sszteljes\u00edtm\u00e9ny, 30 J teljes energia 6 quadricepsz pontra. K\u00e9tf\u00e1zis\u00fa eredm\u00e9ny: 50 J \u00f6sszenergia kev\u00e9sb\u00e9 volt hat\u00e9kony, mint 30 J - a Hormesis\/Arndt-Schulz-g\u00f6rbe egy\u00e9rtelm\u0171 p\u00e9ld\u00e1ja.<\/p>\n\n\n\n<p><strong>Edz\u00e9s el\u0151tti PBM (810 nm): Optim\u00e1lis teljes\u00edtm\u00e9nykibocs\u00e1t\u00e1s az izmok regener\u00e1l\u00f3d\u00e1s\u00e1hoz<\/strong><br><em>Photomed Laser Surg (2017)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29099680\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>RCT 28 labdar\u00fag\u00f3 sportol\u00f3val. \u00d6sszehasonl\u00edtva 100, 200, 400 mW teljes\u00edtm\u00e9nyt di\u00f3d\u00e1nk\u00e9nt (5 di\u00f3da, 810 nm). Eredm\u00e9ny: 100 mW\/di\u00f3da (\u00f6sszesen 500 mW) volt az optim\u00e1lis. A nagyobb teljes\u00edtm\u00e9ny (200, 400 mW) nem mutatott jobb vagy m\u00e9g rosszabb eredm\u00e9nyeket - klasszikus p\u00e9lda: a nagyobb teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g nem automatikusan jobb.<\/p>\n\n\n\n<p><strong>A PBM, az IPC \u00e9s az NMES hat\u00e1sa az izmok regener\u00e1l\u00f3d\u00e1s\u00e1ra: Rendszeres \u00e1ttekint\u00e9s<\/strong><br><em>Journal of Bodywork and Movement Therapies (2025)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40954632\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>19 RCT, 672 r\u00e9sztvev\u0151. A PBM-el\u0151k\u00e9pz\u00e9s -12,27 ponttal cs\u00f6kkentette a f\u00e1jdalmat (95%-KI -18,14 \u00e9s -6,40 k\u00f6z\u00f6tt; I\u00b2 = 48%). A PBM volt az egyetlen m\u00f3dszer (szemben az IPC-vel \u00e9s az NMES-sel), amely szignifik\u00e1ns el\u0151ny\u00f6kkel j\u00e1rt. Aj\u00e1nlott param\u00e9terek: 810-850 nm, 50-100 mW\/cm\u00b2, 6-10 J\/cm\u00b2.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gehirn_Kognition_Neurologie_810%E2%80%931064_nm\"><\/span>Agy, megismer\u00e9s \u00e9s neurol\u00f3gia (810-1,064 nm)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A transzkrani\u00e1lis PBM-nek sz\u00e1mos biol\u00f3giai akad\u00e1lyt kell lek\u00fczdenie (fejb\u0151r, koponyacsontok, agyh\u00e1rtya, liquor, agyk\u00e9reg). A sz\u00fcks\u00e9ges teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9gek ez\u00e9rt l\u00e9nyegesen nagyobbak, mint a felsz\u00edni alkalmaz\u00e1sokn\u00e1l. Egy 2024-es szisztematikus \u00e1ttekint\u00e9s (97 tanulm\u00e1ny, 2133 forr\u00e1s) meg\u00e1llap\u00edtotta: A tanulm\u00e1nyok jellemz\u0151en ~250 mW\/cm\u00b2-t haszn\u00e1lnak a felsz\u00ednen - ennek csak t\u00f6red\u00e9ke \u00e9ri el az agysz\u00f6vetet. Kortik\u00e1lis neuronok eset\u00e9ben: optim\u00e1lis ATP-termel\u00e9s 25 mW\/cm\u00b2, 3 J\/cm\u00b2. A mitokondriumok k\u00e1rosod\u00e1sa m\u00e1r 30 J\/cm\u00b2-n\u00e9l bek\u00f6vetkezett (t\u00fal nagy d\u00f3zis = g\u00e1tl\u00f3 hat\u00e1s\u00fa).<\/p>\n\n\n\n<p><strong>Param\u00e9terek<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>hull\u00e1mhossz 810 nm (megismer\u00e9s\/Alzheimer-k\u00f3r), 1,064 nm (m\u00e9ly behatol\u00e1s\/TBI)<\/li>\n\n\n\n<li>Teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g 25-285 mW\/cm\u00b2 a fejb\u0151r\u00f6n (a c\u00e9lsz\u00f6vet: a k\u00e9reg ennek egy t\u00f6red\u00e9k\u00e9t kapja).<\/li>\n\n\n\n<li>Energias\u0171r\u0171s\u00e9g 20-60 J\/cm\u00b2 (fel\u00fclet); 3 J\/cm\u00b2 a c\u00e9lsz\u00f6vetben (idegsejtek)<\/li>\n\n\n\n<li>Id\u0151tartam 10-20 perc | 3\u00d7\/h\u00e9t (12 h\u00e9t az Alzheimer-k\u00f3r RCT-k eset\u00e9ben)<\/li>\n\n\n\n<li>Legal\u00e1bb 8-12 h\u00e9t a kognit\u00edv hat\u00e1sok eset\u00e9ben; akut hat\u00e1sok 1-2 h\u00e9tig a TBI eset\u00e9ben.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mechanismen_allgemeine_Wirkungen\"><\/span>Mechanizmusok \u00e9s \u00e1ltal\u00e1nos hat\u00e1sok<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>Fotobiomodul\u00e1ci\u00f3s ter\u00e1pia az agyon: forradalmas\u00edtja a kognit\u00edv dinamik\u00e1t<\/strong><br><em>MDPI sejtek (2024)<\/em> <a href=\"https:\/\/www.mdpi.com\/2073-4409\/13\/11\/966\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>A PBM aktiv\u00e1lja a citokr\u00f3m c oxid\u00e1zt a neuron\u00e1lis mitokondriumokban, n\u00f6veli a BDNF-et. A 810 nm er\u0151sebb CCO aktiv\u00e1ci\u00f3t mutat, mint az 1,064 nm (CCO abszorpci\u00f3s cs\u00facs ~810 nm-en). Az 1,064 nm viszont er\u0151sebb hat\u00e1st gyakorol a Ca\u00b2\u207a-csatorn\u00e1kra. Klinikai param\u00e9terkonszenzus: 810 nm, 250 mW\/cm\u00b2 fel\u00fclet, 20-60 J\/cm\u00b2, transzkrani\u00e1lisan a prefront\u00e1lis k\u00e9reg \u00e9s a tempor\u00e1lis lebenyeken.<\/p>\n\n\n\n<p><strong>Agy PBM narrat\u00edv fel\u00fclvizsg\u00e1lata: Mechanizmusok, d\u00f3zisok, j\u00f6v\u0151beli trendek<\/strong><br><em>PMC (Brain Photobiomodulation Review) (2018)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6041198\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>Kulcsparam\u00e9terek: Kortik\u00e1lis neuronok (teny\u00e9sztett): 25 mW\/cm\u00b2, optim\u00e1lis ATP-termel\u00e9s 3 J\/cm\u00b2-n\u00e9l. Nagyobb d\u00f3zisok (10 J\/cm\u00b2) kev\u00e9sb\u00e9 stimul\u00e1lnak, 30 J\/cm\u00b2 mitokondri\u00e1lis k\u00e1rosod\u00e1shoz vezet. M\u00e9lyebb agyi r\u00e9gi\u00f3kra (baz\u00e1lis ganglionok, agyt\u00f6rzs Parkinson-k\u00f3rban): oszt\u00e1ly\u00fa l\u00e9zer (10-15 W) aj\u00e1nlott a 3. oszt\u00e1ly\u00fa (&lt;0,5 W) helyett, hogy elegend\u0151 fluencia jusson a m\u00e9lybe.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Alzheimer_Demenz\"><\/span>Alzheimer-k\u00f3r \u00e9s demencia<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>Agy PBM: potenci\u00e1lis kezel\u00e9s az Alzheimer- \u00e9s Parkinson-k\u00f3rban<\/strong><br><em>PMC (2025)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12321612\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>Preklinikai vizsg\u00e1latok: 808-810 nm, impulzus (40 Hz), naponta vagy 3\u00d7\/h\u00e9t, 12 h\u00e9tig. Az amiloid b\u00e9ta, ox. Stressz, neuroinflamm\u00e1ci\u00f3; jobb kognit\u00edv eredm\u00e9nyek \u00e1llatmodellben. Klinikai vizsg\u00e1lat (Jap\u00e1n): 810 nm-es impulzusf\u00e9ny (40 Hz), 3\u00d7\/h\u00e9t, 12 h\u00e9t, eredm\u00e9ny: szignifik\u00e1nsan jobb ADAS-Cog pontsz\u00e1mok.<\/p>\n\n\n\n<p><strong>Transzkrani\u00e1lis PBM Alzheimer-k\u00f3rban: RCT protokoll (Jap\u00e1n)<\/strong><br><em>Frontiers in Neurology (2024)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11258032\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>Teljesen le\u00edrt RCT param\u00e9terek: 810 nm, impulzus 40 Hz, 250 mW\/cm\u00b2, 20 perc\/\u00fcl\u00e9s, 3\u00d7\/h\u00e9t, 12 h\u00e9t. Az EEG-m\u00e9r\u00e9sek javul\u00f3 alfa\/b\u00e9ta\/gamma ritmust mutattak. Els\u0151dleges v\u00e9gpont ADAS-Cog (Alzheimer-k\u00f3r megismer\u00e9si sk\u00e1la). Prospekt\u00edv, l\u00e1tszat-kontroll\u00e1lt vizsg\u00e1lat.<\/p>\n\n\n\n<p><strong>A transzkrani\u00e1lis PBM jav\u00edtja a kognit\u00edv funkci\u00f3kat, a PTSD-t \u00e9s a poszt-konk\u00fazi\u00f3s t\u00fcneteket<\/strong><br><em>Journal of Neurotrauma (2025)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40485299\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>RCT, 17 TBI-p\u00e1ciens. Param\u00e9terek: 810 nm vagy 1064 nm, 250 mW\/cm\u00b2, 20 J\/cm\u00b2, 10 perc\/\u00fcl\u00e9s. Jelent\u0151s javul\u00e1s a kognit\u00edv funkci\u00f3kban, a PTSD-ben \u00e9s a poszt-konk\u00fazi\u00f3s t\u00fcnetekben. Placebo-kontroll\u00e1lt.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"TBI_Entgiftung_1064_nm\"><\/span>TBI \u00e9s m\u00e9regtelen\u00edt\u00e9s (1,064 nm)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>1064 nm PBM el\u0151seg\u00edti a TBI helyre\u00e1ll\u00edt\u00e1st a neuroinflamm\u00e1ci\u00f3 modul\u00e1l\u00e1s\u00e1val<\/strong><br><em>Journal of Translational Medicine (2025)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41204266\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>Eg\u00e9rmodell: 1064 nm-es LED, 25 mW\/cm\u00b2, 12 perc\/nap (= 18 J\/cm\u00b2), 14 nap. Jelent\u0151s gy\u00f3gyul\u00e1s TBI ut\u00e1n, a kognit\u00edv \u00e9s \u00e9rzelmi k\u00e1rosod\u00e1sok enyh\u00fcl\u00e9se. A BDNF \u00e9s a VEGF jelent\u0151sen megn\u00f6vekedett a kezelt ter\u00fcleten. Mechanizmus: A mikroglia polariz\u00e1ci\u00f3 \u00e9s a neuroinflamm\u00e1ci\u00f3 modul\u00e1ci\u00f3ja.<\/p>\n\n\n\n<p><strong>PBM \u00e9s a glimfatikus rendszer: Az agyi nyirokelvezet\u00e9s fokoz\u00e1sa<\/strong><br><em>Int. J. Mol. Sci. (2022)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8950470\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>\u00c1llatk\u00eds\u00e9rletek: a PBM (810 nm, 25-50 mW\/cm\u00b2) jav\u00edtja az agyh\u00e1rtya nyirok\u00e1raml\u00e1s\u00e1t, el\u0151seg\u00edti az amiloid b\u00e9ta ki\u00fcr\u00fcl\u00e9s\u00e9t a glimfatikus rendszeren kereszt\u00fcl. Ter\u00e1pi\u00e1s implik\u00e1ci\u00f3: Az agy m\u00e9regtelen\u00edt\u0151 funkci\u00f3ja - az Alzheimer-k\u00f3r megel\u0151z\u00e9se \u00e9s az \u00e1ltal\u00e1nos agyi eg\u00e9szs\u00e9g szempontj\u00e1b\u00f3l.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Schmerzmanagement\"><\/span>F\u00e1jdalomcsillap\u00edt\u00e1s<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>A PBM t\u00f6bb mechanizmuson kereszt\u00fcl fejti ki f\u00e1jdalomcsillap\u00edt\u00f3 hat\u00e1s\u00e1t: a pro-inflammatorikus citokinek (TNF-\u03b1, IL-6, IL-1\u03b2) cs\u00f6kkent\u00e9se, a nocicept\u00edv C- \u00e9s A\u03b4-rostok modul\u00e1ci\u00f3ja, az endorfin felszabadul\u00e1s\u00e1nak n\u00f6vel\u00e9se \u00e9s a helyi mikrocirkul\u00e1ci\u00f3 jav\u00edt\u00e1sa. Fel\u00fcletes f\u00e1jdalompontok (\u00e9rz\u00e9keny pontok, triggerpontok) eset\u00e9n: 630-660 nm elegend\u0151. M\u00e9lyebb mozg\u00e1sszervi strukt\u00far\u00e1k (\u00edz\u00fcletek, gerinc) eset\u00e9n: 780-905 nm, nagyobb teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9ggel.<\/p>\n\n\n\n<p><strong>Param\u00e9terek<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>630-905 nm hull\u00e1mhossz (a f\u00e1jdalompont m\u00e9lys\u00e9g\u00e9t\u0151l f\u00fcgg\u0151en)<\/li>\n\n\n\n<li>Teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g 40-100 mW\/cm\u00b2 (felsz\u00edni: 40-60; m\u00e9ly: 60-100)<\/li>\n\n\n\n<li>Energias\u0171r\u0171s\u00e9g 4-10 J\/cm\u00b2 pontonk\u00e9nt (fibromyalgia eset\u00e9n: ak\u00e1r 150 J\/cm\u00b2 eg\u00e9sz testre)<\/li>\n\n\n\n<li>Id\u0151tartam 10-20 perc\/\u00fcl\u00e9s<\/li>\n\n\n\n<li>Gyakoris\u00e1g 3\u00d7\/h\u00e9t, 6-12 h\u00e9t; fibromyalgia: 4-6 h\u00e9t intenz\u00edv + nyomon k\u00f6vet\u00e9s<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ubergreifende_Reviews\"><\/span>\u00c1tfog\u00f3 fel\u00fclvizsg\u00e1latok<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>A PBM hat\u00e1sa t\u00f6bb eg\u00e9szs\u00e9g\u00fcgyi kimenetre: az RCT-k \u00e1tfog\u00f3 \u00e1ttekint\u00e9se<\/strong><br><em>Rendszeres \u00e1ttekint\u00e9sek (Springer) (2025)<\/em> <a href=\"https:\/\/link.springer.com\/article\/10.1186\/s13643-025-02902-3\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>15 metaanal\u00edzis, &gt; 9000 beteg, 35 v\u00e9gpont, 15 betegs\u00e9g. A leger\u0151sebb bizony\u00edt\u00e9kok a fibromyalgi\u00e1ra, a t\u00e9rd\u00edz\u00fcleti artritiszes rokkants\u00e1gra \u00e9s a kognit\u00edv k\u00e1rosod\u00e1sra vonatkoznak. A PBM-protokollok sz\u00e9les k\u00f6rben v\u00e1ltoznak - nincs egys\u00e9ges szabv\u00e1ny, ami megnehez\u00edti az \u00f6sszehasonl\u00edthat\u00f3s\u00e1got. GRADE min\u0151s\u00e9g: 17% k\u00f6zepes, 57% alacsony, 26% nagyon alacsony.<\/p>\n\n\n\n<p><strong>PBM kr\u00f3nikus f\u00e1jdalomban: az RCT-k szisztematikus \u00e1ttekint\u00e9se<\/strong><br><em>Hat\u00e1rok az integrat\u00edv idegtudom\u00e1nyban (2026)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/integrative-neuroscience\/articles\/10.3389\/fnint.2026.1717372\/full\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>14 RCT, 6 611 \u00e1tvizsg\u00e1lt cikk. A leger\u0151sebb eredm\u00e9nyek a fibromyalgia \u00e9s a perif\u00e9ri\u00e1s neurop\u00e1ti\u00e1k eset\u00e9ben sz\u00fclettek: a VAS cs\u00f6kken\u00e9se szignifik\u00e1ns (p = 0,010), a f\u00e1jdalmas pontok szignifik\u00e1nsan cs\u00f6kkentek (p &lt; 0,0001). Aj\u00e1nlott param\u00e9terek neurop\u00e1ti\u00e1s f\u00e1jdalom eset\u00e9n: 660-830 nm, 40-80 mW\/cm\u00b2, 4-6 J\/cm\u00b2, heti 3\u00d7.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Fibromyalgie\"><\/span>Fibromyalgia<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>A PBMT hat\u00e9konys\u00e1ga fibromyalgi\u00e1ban: Rendszeres \u00e1ttekint\u00e9s (17 tanulm\u00e1ny)<\/strong><br><em>MDPI Alkalmazott tudom\u00e1nyok (2025)<\/em> <a href=\"https:\/\/www.mdpi.com\/2076-3417\/15\/8\/4161\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>857 r\u00e9sztvev\u0151. Alkalmazott k\u00e9sz\u00fcl\u00e9kek: alacsony szint\u0171 l\u00e9zer, infrav\u00f6r\u00f6s LED, eg\u00e9sz testet megvil\u00e1g\u00edt\u00f3 \u00e1gyak (NovoTHOR). Az eg\u00e9sz testre kiterjed\u0151 PBM (630-1 100 nm, v\u00e1ltoz\u00f3 fluencia 1-150 J\/cm\u00b2) legal\u00e1bb egyen\u00e9rt\u00e9k\u0171 volt a lokaliz\u00e1lt PBM-mel. Mechanizmus: Az oxidat\u00edv stressz, a mitokondri\u00e1lis funkci\u00f3 \u00e9s a nocicept\u00edv jel\u00e1tviteli utak modul\u00e1ci\u00f3ja. Aj\u00e1nl\u00e1s: Az eg\u00e9sz testet \u00e9rint\u0151 megk\u00f6zel\u00edt\u00e9s el\u0151ny\u00f6sebb a kiterjedt f\u00e1jdalompontok eset\u00e9ben.<\/p>\n\n\n\n<p><strong>Eg\u00e9sz testre kiterjed\u0151 PBM a f\u00e1jdalomra, az \u00e9letmin\u0151s\u00e9gre \u00e9s a kineziof\u00f3bi\u00e1ra: h\u00e1romszorosan vak RCT, 6 h\u00f3napos ut\u00e1nk\u00f6vet\u00e9s<\/strong><br><em>Az idegtudom\u00e1nyok hat\u00e1rai (2024)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/neuroscience\/articles\/10.3389\/fnins.2024.1264821\/full\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>42 beteg, NovoTHOR teljes test\u00e1gy (660 + 850 nm, szabadalmaztatott teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g). 12 kezel\u00e9si \u00fcl\u00e9s. Jelent\u0151s f\u00e1jdalomcs\u00f6kken\u00e9s T2-ben (a kezel\u00e9s ut\u00e1n), T3-ban (2 hetes k\u00f6vet\u00e9s) \u00e9s T4\/T5-ben (3 \u00e9s 6 h\u00f3nap). Az eg\u00e9sz testre kiterjed\u0151 PBM hat\u00e9konyabban kezeli a sziszt\u00e9m\u00e1s fibromyalgia patol\u00f3gi\u00e1j\u00e1t, mint a szelekt\u00edv alkalmaz\u00e1s.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kniearthrose_Tendinopathie\"><\/span>T\u00e9rd\u00edz\u00fcleti csontritisz \u00e9s \u00ednh\u00fcvelygyullad\u00e1s<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>PBM a t\u00e9rd osteoarthritisben: Rendszeres \u00e1ttekint\u00e9s \u00e9s metaanal\u00edzis (10 RCT)<\/strong><br><em>Fizikoter\u00e1pia (2024)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38775202\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>542 r\u00e9sztvev\u0151. A leghat\u00e9konyabb param\u00e9terek: 810-830 nm, 50-100 mW\/cm\u00b2, 4-10 J\/cm\u00b2 a t\u00e9rd\u00edz\u00fcleti t\u00e9rben, 10-20 perc, 3\u00d7\/h\u00e9t. M\u00e9rs\u00e9kelt bizony\u00edt\u00e9k a f\u00e1jdalomcs\u00f6kkent\u00e9sre \u00e9s a funkcion\u00e1lis javul\u00e1sra. Megjegyz\u00e9s: A t\u00e9rd\u00edz\u00fclet m\u00e9lyebben van, mint a b\u0151rfel\u00fclet - ez\u00e9rt a 810-850 nm (m\u00e9lyebb behatol\u00e1s) el\u0151ny\u00f6sebb a 660 nm-n\u00e9l.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Neuropathischer_Schmerz\"><\/span>Neurop\u00e1ti\u00e1s f\u00e1jdalom<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>PBM a neurop\u00e1ti\u00e1s f\u00e1jdalomban: mechanizmusok, bizony\u00edt\u00e9kok \u00e9s j\u00f6v\u0151beli ir\u00e1nyok<\/strong><br><em>Hat\u00e1rok a fotonik\u00e1ban (2025)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/photonics\/articles\/10.3389\/fphot.2025.1730347\/full\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>A 660 nm m\u00e1s fotoakceptorokat aktiv\u00e1l, mint a 810-850 nm. Fel\u00fcletes neurop\u00e1tia (pl. posztherpeszes neuralgia) eset\u00e9n: 660 nm, 20-50 mW\/cm\u00b2, 4-6 J\/cm\u00b2. M\u00e9ly neurop\u00e1tia eset\u00e9n (pl. diab\u00e9teszes polineurop\u00e1tia l\u00e1b): 810-830 nm, 50-100 mW\/cm\u00b2, 6-10 J\/cm\u00b2. Mechanizmus: A PBM neuroprotekt\u00edv hat\u00e1st v\u00e1lt ki a BDNF szint\u00e9zis\u00e9n \u00e9s a neuroinflamm\u00e1ci\u00f3 elfojt\u00e1s\u00e1n kereszt\u00fcl.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Augenheilkunde_AMD\"><\/span>Szem\u00e9szet (AMD)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Szem\u00e9szeti alkalmaz\u00e1sokra (k\u00fcl\u00f6n\u00f6sen AMD) speci\u00e1lis adagol\u00e1si szab\u00e1lyok vonatkoznak: A retina besug\u00e1rz\u00e1si s\u0171r\u0171s\u00e9ge (ami t\u00e9nylegesen el\u00e9ri a retin\u00e1t) drasztikusan alacsonyabb, mint a k\u00e9sz\u00fcl\u00e9k teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9ge. Az olyan k\u00e9sz\u00fcl\u00e9kek, mint a fotobiomodul\u00e1ci\u00f3s szem\u00fcvegek (LumiThera) a pupill\u00e1n kereszt\u00fcl bocs\u00e1tj\u00e1k ki a f\u00e9nyt - k\u00f6zvetlen\u00fcl a makul\u00e1ra. Ez\u00e9rt m\u00e1r 0,3-15 \u03bcW\/cm\u00b2 retin\u00e1lis besug\u00e1rz\u00e1s is elegend\u0151 lehet. Vigy\u00e1zat: A helytelen adagol\u00e1s retinak\u00e1rosod\u00e1st okozhat. Csak enged\u00e9lyezett szem\u00e9szeti PBM k\u00e9sz\u00fcl\u00e9keket haszn\u00e1ljon!<\/p>\n\n\n\n<p><strong>Param\u00e9terek<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>590 nm + 660 nm + 850 nm hull\u00e1mhossz (t\u00f6bb hull\u00e1mhossz, pl. LIGHTSITE III)<\/li>\n\n\n\n<li>Teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g 0,3-15 \u03bcW\/cm\u00b2 (retina); k\u00e9sz\u00fcl\u00e9k ~600 \u03bcW\/cm\u00b2 fel\u00fclet\u0171 k\u00e9sz\u00fcl\u00e9k<\/li>\n\n\n\n<li>Nagyon alacsony energias\u0171r\u0171s\u00e9g, apr\u00f3l\u00e9kosan kalibr\u00e1lva<\/li>\n\n\n\n<li>Id\u0151tartam 3-10 perc\/\u00fcl\u00e9s, 3\u00d7 hetente 3-13 h\u00f3napon kereszt\u00fcl<\/li>\n\n\n\n<li>Hossz\u00fa t\u00e1v\u00fa haszn\u00e1lat; 3 havonta ellen\u0151rizze<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Altersbedingte_Makuladegeneration\"><\/span>Id\u0151skori makuladegener\u00e1ci\u00f3<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>LIGHTSITE III: PBM (590+660+850 nm) sz\u00e1raz AMD-vel<\/strong><br><em>RETINA foly\u00f3irat (2024)<\/em> <a href=\"https:\/\/journals.lww.com\/retinajournal\/fulltext\/2024\/03000\/lightsite_iii__13_month_efficacy_and_safety.14.aspx\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>100 beteg, 10 amerikai k\u00f6zpont, 13 h\u00f3nap. Eszk\u00f6z: LumiThera Valeda f\u00e9nybeviteli rendszer. Hull\u00e1mhossz: 590 + 660 + 850 nm szekvenci\u00e1lisan. Kezel\u00e9s: 3\u00d7\/h\u00e9t 3 h\u00f3napig, majd ism\u00e9telt kezel\u00e9si ciklusok. Eredm\u00e9ny: +5,4 bet\u0171 l\u00e1t\u00e1s\u00e9less\u00e9g (ETDRS) vs. l\u00e1tszat, &lt;1% \u00faj geogr\u00e1fiai atr\u00f3fia vs. 9,8% a l\u00e1tszatkarban - statisztikailag magasan szignifik\u00e1ns.<\/p>\n\n\n\n<p><strong>PBM4AMD: R\u00f6vid t\u00e1v\u00fa hat\u00e9konys\u00e1g korai\/k\u00f6zepes AMD-ben<\/strong><br><em>Szem (term\u00e9szet) (2024)<\/em> <a href=\"https:\/\/www.nature.com\/articles\/s41433-024-03326-4\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>38 r\u00e9sztvev\u0151, 12 h\u00e9t. Param\u00e9terek: T\u00f6bb hull\u00e1mhossz\u00fa (hasonl\u00f3an a LIGHTSITE-hoz), 10 perc\/\u00fcl\u00e9s, 3\u00d7\/h\u00e9t. A l\u00e1t\u00e1s\u00e9less\u00e9g, a kontraszt\u00e9rz\u00e9kenys\u00e9g \u00e9s a s\u00f6t\u00e9tadapt\u00e1ci\u00f3 jelent\u0151sen javult. Biztons\u00e1goss\u00e1g: a retin\u00e1n nem volt termikus vagy struktur\u00e1lis mell\u00e9khat\u00e1s.<\/p>\n\n\n\n<p><strong>PBM alkalmaz\u00e1sa a szem\u00e9szetben: a padr\u00f3l a beteg\u00e1gyra<\/strong><br><em>Frontiers in Ophthalmology (2024)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/ophthalmology\/articles\/10.3389\/fopht.2024.1388602\/full\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>Megmagyar\u00e1zza a szem\u00e9szetben a bonyolult param\u00e9terhelyzetet: a retina besug\u00e1rz\u00e1sa a d\u00f6nt\u0151, nem a k\u00e9sz\u00fcl\u00e9k teljes\u00edtm\u00e9nye. A 630 nm-en v\u00e9gzett k\u00fcl\u00f6nb\u00f6z\u0151 AMD-vizsg\u00e1latok m\u00e1r 15 \u03bcW\/cm\u00b2 mellett is jelent\u0151s retin\u00e1lis javul\u00e1st mutattak ki. Helyes adagol\u00e1s mellett 15 \u00e9v alatt nem volt mell\u00e9khat\u00e1s - fontos: csak kalibr\u00e1lt, szemspecifikus j\u00f3v\u00e1hagy\u00e1ssal rendelkez\u0151 orvosi eszk\u00f6z\u00f6ket haszn\u00e1ljon.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onkologie_Mukositis\"><\/span>Onkol\u00f3gia \u00e9s ny\u00e1lkah\u00e1rtya-gyullad\u00e1s<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A sz\u00e1j\u00fcregi ny\u00e1lkah\u00e1rtya-gyullad\u00e1s a kemoter\u00e1pia\/sug\u00e1rter\u00e1pia leggyakoribb akut mell\u00e9khat\u00e1sa. A PBM-et intraor\u00e1lisan alkalmazz\u00e1k a sz\u00e1jny\u00e1lkah\u00e1rty\u00e1ra megel\u0151z\u0151 int\u00e9zked\u00e9sk\u00e9nt (a r\u00e1kter\u00e1pia el\u0151tt \u00e9s alatt). A MASCC\/ISOO ir\u00e1nymutat\u00e1sok (2019) szerint a PBM az egyetlen olyan nem farmakol\u00f3giai beavatkoz\u00e1s, amely hivatalos aj\u00e1nl\u00e1ssal (A szint) rendelkezik a mukozitisz megel\u0151z\u00e9s\u00e9re a v\u00e9rk\u00e9pz\u0151 \u0151ssejt-transzplant\u00e1ci\u00f3 sor\u00e1n. A hull\u00e1mhossz \u00e9s az adagol\u00e1s a legszabv\u00e1nyosabb ezen a ter\u00fcleten.<\/p>\n\n\n\n<p><strong>Param\u00e9terek<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>630-660 nm hull\u00e1mhossz (intraor\u00e1lis); 650 + 980 nm (kombin\u00e1lt intra+extraor\u00e1lis)<\/li>\n\n\n\n<li>Teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g 10-25 mW\/cm\u00b2 (a MASCC\/ISOO 10-25 mW-os InGaAlP l\u00e9zereket aj\u00e1nl)<\/li>\n\n\n\n<li>Energias\u0171r\u0171s\u00e9g 2-6 J\/cm\u00b2 ny\u00e1lkah\u00e1rtya pontonk\u00e9nt<\/li>\n\n\n\n<li>Id\u0151tartam 3-5 perc\/pont<br>Haszn\u00e1lja naponta vagy felv\u00e1ltva a r\u00e1kter\u00e1pia alatt<\/li>\n\n\n\n<li>Gyakoris\u00e1g Napi kemoter\u00e1pia\/sug\u00e1rter\u00e1pia alatt; legal\u00e1bb 5\u00d7 hetente<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Leitlinien\"><\/span>Ir\u00e1nyelvek<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>MASCC\/ISOO klinikai gyakorlati \u00fatmutat\u00f3 a PBM \u00e9s a sz\u00e1j\u00fcregi ny\u00e1lkah\u00e1rtya-gyullad\u00e1shoz<\/strong><br><em>Support Care Cancer (2019)<\/em> <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s00520-019-04890-2\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>Hivatalos aj\u00e1nl\u00e1s (legmagasabb szint\u0171 bizony\u00edt\u00e9k): hull\u00e1mhossz 632-685 nm (He-Ne vagy InGaAlP), teljes\u00edtm\u00e9ny 10-25 mW, energias\u0171r\u0171s\u00e9g 2-4 J\/cm\u00b2 alkalmaz\u00e1si pontonk\u00e9nt, intraor\u00e1lisan a beteg ter\u00fcleteken. Gyakoris\u00e1g: naponta a kemoter\u00e1pia alatt. Alkalmazhat\u00f3: v\u00e9rk\u00e9pz\u0151 \u0151ssejt-transzplant\u00e1ci\u00f3, fej-nyaki kemoradioter\u00e1pia. Nincs jelent\u0151s mell\u00e9khat\u00e1s 15 \u00e9ves k\u00f6vet\u00e9s ut\u00e1n.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Chemotherapie-induzierte_Mukositis\"><\/span>Kemoter\u00e1pia okozta mucositis<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>Prevent\u00edv PBM a kemoter\u00e1pia \u00e1ltal kiv\u00e1ltott or\u00e1lis mukozitisz kezel\u00e9s\u00e9re: az RCT-k szisztematikus \u00e1ttekint\u00e9se<\/strong><br><em>MDPI Biomedicines (2025)<\/em> <a href=\"https:\/\/www.mdpi.com\/2227-9059\/13\/2\/268\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>13 tanulm\u00e1ny, 828 beteg. Alkalmazott param\u00e9terek: 630-660 nm-es InGaAlP di\u00f3dal\u00e9zer, 10-25 mW, 2-6 J\/cm\u00b2, naponta intraor\u00e1lisan. 211 vs. 128 betegn\u00e9l alakult ki mucositis (kontroll vs. PBM). 85% a vizsg\u00e1latok alacsony torz\u00edt\u00e1si kock\u00e1zattal rendelkeztek. A megel\u0151z\u0151 PBM szignifik\u00e1nsan jobb, mint a reakt\u00edv kezel\u00e9s.<\/p>\n\n\n\n<p><strong>PBM prekondicion\u00e1l\u00e1s sz\u00e1jny\u00e1lkah\u00e1rtya-gyullad\u00e1s eset\u00e9n: kett\u0151s-vak RCT<\/strong><br><em>BMC Oral Health (2025)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11800611\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>45 beteg, 3 csoport. csoport: intraor\u00e1lis 650 nm (4 J\/cm\u00b2). csoport: intraor\u00e1lis 650 nm + extraor\u00e1lis 980 nm. Mindk\u00e9t intervenci\u00f3s csoportban szignifik\u00e1nsan megel\u0151zt\u00e9k a mucositist \u00e9s a xerostomi\u00e1t. Eredm\u00e9ny: A v\u00f6r\u00f6s + infrav\u00f6r\u00f6s f\u00e9ny (650 + 980 nm) kombin\u00e1ci\u00f3ja maxim\u00e1lisan hat\u00e9kony a sz\u00e1j teljes lefedetts\u00e9g\u00e9re.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kopf-Hals-Karzinome_Strahlentherapie\"><\/span>Fej-nyaki r\u00e1k \u00e9s sug\u00e1rter\u00e1pia<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>PBM a fej- \u00e9s nyaki r\u00e1kos betegek sz\u00e1jny\u00e1lkah\u00e1rtya-gyullad\u00e1s\u00e1nak kezel\u00e9s\u00e9re: 14 RCT metaanal\u00edzise<\/strong><br><em>Fej \u00e9s nyak (Wiley) (2024)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38265122\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>869 beteg. Param\u00e9terelemz\u00e9s: He-Ne \u00e9s InGaAlP l\u00e9zer (630-660 nm), 10-25 mW, 2-6 J\/cm\u00b2, napi alkalmaz\u00e1s a sug\u00e1rter\u00e1pia sor\u00e1n mutatta a legjobb eredm\u00e9nyeket. A mucositis relat\u00edv kock\u00e1zat\u00e1nak cs\u00f6kken\u00e9se: RR = 0,49 (p = 0,04) a 2. h\u00e9tt\u0151l. F\u00e1jdalomcs\u00f6kken\u00e9s: WMD = -1,09 (p &lt; 0,00001). Magasan szignifik\u00e1ns hat\u00e9konys\u00e1g a sug\u00e1rter\u00e1pia 7 hete alatt.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Immunsystem_Entzundung\"><\/span>Immunrendszer \u00e9s gyullad\u00e1s<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A PBM kontextusf\u00fcgg\u0151 m\u00f3don befoly\u00e1solja az immunrendszert: Gyulladt sz\u00f6vetekben gyullad\u00e1scs\u00f6kkent\u0151 hat\u00e1s\u00fa (cs\u00f6kkenti a TNF-\u03b1, IL-6, IL-1\u03b2 \u00e9rt\u00e9keket; el\u0151seg\u00edti az M2 makrof\u00e1gok polariz\u00e1ci\u00f3j\u00e1t), eg\u00e9szs\u00e9ges sz\u00f6vetekben serkent\u0151 hat\u00e1s\u00fa. Az immunmodul\u00e1l\u00f3 hat\u00e1st az optikai ablakban (650-950 nm) mutatt\u00e1k ki, 1-10 J\/cm\u00b2 d\u00f3zisfolyos\u00f3 mellett. Fontos: Ezek a d\u00f3zisok l\u00e9nyegesen alacsonyabbak, mint az izom alkalmaz\u00e1s\u00e1n\u00e1l - az immunrendszer \u00e9rz\u00e9kenyebben reag\u00e1l.<\/p>\n\n\n\n<p><strong>Param\u00e9terek<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>650-950 nm hull\u00e1mhossz (legsz\u00e9lesebb hat\u00e1sos spektrum; 660 + 850 nm kombin\u00e1ci\u00f3 aj\u00e1nlott)<\/li>\n\n\n\n<li>Teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g 20-80 mW\/cm\u00b2<\/li>\n\n\n\n<li>Energias\u0171r\u0171s\u00e9g 1-10 J\/cm\u00b2 (immunmodul\u00e1ci\u00f3)<br>A nagyobb d\u00f3zisok immunszuppressz\u00edv hat\u00e1s\u00faak lehetnek.<\/li>\n\n\n\n<li>Id\u0151tartam 5-15 perc\/\u00fcl\u00e9s<\/li>\n\n\n\n<li>3\u00d7\/h\u00e9t; akut gyullad\u00e1s eset\u00e9n az els\u0151 h\u00e9ten naponta<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Immunmodulation\"><\/span>Immunmodul\u00e1ci\u00f3<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>A PBM immunmodul\u00e1l\u00f3 hat\u00e1sai: \u00e1tfog\u00f3 \u00e1ttekint\u00e9s<\/strong><br><em>L\u00e9zerek az orvostudom\u00e1nyban (2025)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11991943\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>Optim\u00e1lis param\u00e9terek az immunmodul\u00e1ci\u00f3hoz: 650-950 nm, 20-80 mW\/cm\u00b2, 1-10 J\/cm\u00b2. A PBM befoly\u00e1solja a dendritikus sejteket (migr\u00e1ci\u00f3, citokintermel\u00e9s), el\u0151seg\u00edti a makrof\u00e1gok M2 polariz\u00e1ci\u00f3j\u00e1t \u00e9s szab\u00e1lyozza a T-sejt v\u00e1laszokat. Fontos meg\u00e1llap\u00edt\u00e1s: mind\u00f6ssze 1 J\/cm\u00b2 elegend\u0151 a m\u00e9rhet\u0151 immunol\u00f3giai hat\u00e1sokhoz - j\u00f3val az izom\/csont eset\u00e9ben aj\u00e1nlott d\u00f3zisok alatt.<\/p>\n\n\n\n<p><strong>A PBM ter\u00e1pia hat\u00e9konys\u00e1ga a f\u00e1jdalom \u00e9s a gyullad\u00e1s kezel\u00e9s\u00e9ben: Irodalmi \u00e1ttekint\u00e9s<\/strong><br><em>PMC (2023)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10094541\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>PBM 600-1 070 nm, energias\u0171r\u0171s\u00e9g 1-150 J\/cm\u00b2. Optim\u00e1lis a gyullad\u00e1sg\u00e1tl\u00e1shoz: 780-950 nm, 40-80 mW\/cm\u00b2, 4-10 J\/cm\u00b2, 3\u00d7\/h\u00e9t. Az eg\u00e9sz testre kiterjed\u0151 PBM sziszt\u00e9m\u00e1s immunhat\u00e1sokat mutatott: javult az alv\u00e1s min\u0151s\u00e9ge, a reggeli merevs\u00e9g, az izomg\u00f6rcs\u00f6k cs\u00f6kken\u00e9se, pszichol\u00f3giai t\u00e9nyez\u0151k. K\u00fcl\u00f6n\u00f6sen fontos a kr\u00f3nikus gyullad\u00e1sos sziszt\u00e9m\u00e1s betegs\u00e9gek (pl. fibromyalgia, RA) eset\u00e9ben.<\/p>\n\n\n\n<p><strong>A f\u00e9nyparam\u00e9terek \u00e9s a PBM hat\u00e9konys\u00e1g\u00e1nak \u00e1ttekint\u00e9se (Hamblin, Harvard)<\/strong><br><em>J. Biomed. Optics (PMC) (2021)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8355782\/\" target=\"_blank\" rel=\"noopener\">Teljes sz\u00f6veg \/ PubMed<\/a><\/p>\n\n\n\n<p>Alapvet\u0151 munka a param\u00e9terek meghat\u00e1roz\u00e1s\u00e1ra (Hamblin\/Harvard). K\u00f6zponti meg\u00e1llap\u00edt\u00e1s: Nincs \u00e1ltal\u00e1nos egyet\u00e9rt\u00e9s az optim\u00e1lis param\u00e9tereket illet\u0151en - a konzervat\u00edv aj\u00e1nl\u00e1s konszenzusosnak tekinthet\u0151 a &lt; 100 mW\/cm\u00b2 teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g \u00e9s a 4-10 J\/cm\u00b2 energias\u0171r\u0171s\u00e9g a c\u00e9lsz\u00f6vetben. K\u00e9tf\u00e1zis\u00fa d\u00f3zisv\u00e1lasz (Arndt-Schulz): sejtstimul\u00e1ci\u00f3 0,5-10 J\/cm\u00b2 k\u00f6z\u00f6tt, g\u00e1tl\u00e1s ~30 J\/cm\u00b2 felett. A magas mitokondriumtartalm\u00fa sz\u00f6vetek (izom, ideg, sz\u00edv, agy) t\u00f6bb energi\u00e1t ig\u00e9nyelnek, mint az alacsony mitokondriumtartalm\u00fa sz\u00f6vetek (b\u0151r, \u00edn, porc).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Klinische_Empfehlungen\"><\/span>Klinikai aj\u00e1nl\u00e1sok<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>A fotobiomodul\u00e1ci\u00f3 az els\u0151 olyan nem invaz\u00edv ter\u00e1pi\u00e1s m\u00f3dozat, amelynek klinikai hat\u00e9konys\u00e1ga legal\u00e1bb 7 k\u00fcl\u00f6nb\u00f6z\u0151 orvosi szakter\u00fcleten bizony\u00edtott. A bizony\u00edt\u00e9kok er\u0151ss\u00e9ge v\u00e1ltoz\u00f3: A legmegb\u00edzhat\u00f3bb adatok a sz\u00e1jny\u00e1lkah\u00e1rtya-gyullad\u00e1sra (MASCC\/ISOO-ir\u00e1nyelv), a sebgy\u00f3gyul\u00e1sra (LoE I metaanal\u00edzis) \u00e9s a sportban t\u00f6rt\u00e9n\u0151 izomregener\u00e1ci\u00f3ra vonatkoznak. Az agy\/neurol\u00f3gia \u00e9s az AMD ter\u00fcletei nagyon \u00edg\u00e9retesek, de m\u00e9g fejleszt\u00e9s alatt \u00e1llnak.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Allgemeine_Dosierungsregeln_Konsensus\"><\/span>\u00c1ltal\u00e1nos adagol\u00e1si szab\u00e1lyok (konszenzus)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>Felsz\u00edv\u00f3dott d\u00f3zis<\/strong><br>5-50 Joule \u00f6sszesen \u00fcl\u00e9senk\u00e9nt (ir\u00e1nyad\u00f3: ~25 J)<\/p>\n\n\n\n<p><strong>C\u00e9lonk\u00e9nti hull\u00e1mhossz<\/strong><br>660 nm b\u0151r\/fel\u00fclet eset\u00e9n<br>810-850 nm izmok\/\u00edz\u00fcletek\/m\u00e9ly sz\u00f6vetek eset\u00e9ben<br>1,050-1,064 nm az agy eset\u00e9ben<\/p>\n\n\n\n<p><strong>Teljes\u00edtm\u00e9nys\u0171r\u0171s\u00e9g m\u00e9lys\u00e9genk\u00e9nt<\/strong><br>B\u0151r 6-50 mW\/cm\u00b2<br>Izmok 50-100 mW\/cm\u00b2<br>Agy (transzkrani\u00e1lis) 25-285 mW\/cm\u00b2<\/p>\n\n\n\n<p><strong>Figyelje meg a bif\u00e1zisokat<\/strong><br>A nagyobb d\u00f3zisok nem jelentenek automatikusan jobb eredm\u00e9nyt.<br>- B\u0151r: max. 20 J\/cm\u00b2<br>- Idegsejtek: max. 10 J\/cm\u00b2 a c\u00e9lsz\u00f6veten.<br>- izmok eset\u00e9ben: max. 30-50 J\/cm\u00b2<\/p>\n\n\n\n<p><strong>Kombin\u00e1lt eszk\u00f6z\u00f6k<\/strong> - 660 + 850 nm a legsz\u00e9lesebb spektrumot k\u00edn\u00e1lja; ~50% t\u00f6bb kezel\u00e9si id\u0151t ig\u00e9nyel<\/p>\n\n\n\n<p><strong>Kezel\u00e9si intervallum<\/strong><br>Napi 3\u00d7\/h\u00e9t; a sejtek regener\u00e1l\u00f3d\u00e1sa \u00e9rdek\u00e9ben 1-2 naponta aj\u00e1nlott sz\u00fcnetet tartani.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Evidenzstarke_nach_Bereich\"><\/span>A bizony\u00edt\u00e9kok er\u0151ss\u00e9ge ter\u00fcletenk\u00e9nt<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>Nagyon er\u0151s (LoE I, WALT\/MASCC ir\u00e1nymutat\u00e1sok)<\/strong><br>- Mucositis a r\u00e1kban<br>- Sebgy\u00f3gyul\u00e1s<br>- Kollag\u00e9n\/b\u0151r<\/p>\n\n\n\n<p><strong>Er\u0151s (LoE I, metaanal\u00edzisek)<\/strong><br>- Izomregener\u00e1ci\u00f3<br>- Fibromyalgia<br>- AMD<\/p>\n\n\n\n<p><strong>M\u00e9rs\u00e9kelt (LoE II, RCT-k)<\/strong><br>- T\u00e9rd\u00edz\u00fcleti arthrosis<br>- neurop\u00e1ti\u00e1s f\u00e1jdalom<br>- Kogn\u00edci\u00f3 (transzkrani\u00e1lis)<\/p>\n\n\n\n<p><strong>Korai (preklinikai\/pil\u00f3ta)<\/strong><br>- M\u00e9regtelen\u00edt\u00e9s, nyirokrendszer<br>- Hossz\u00fa t\u00e1v\u00fa r\u00e1kos t\u00fal\u00e9l\u00e9s<br>- 1,064 nm m\u00e9ly agyi strukt\u00far\u00e1k<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kontakt_zu_PBM-Anwendern_%E2%80%93_Arzte_Kliniken\"><\/span>Kapcsolat a PBM felhaszn\u00e1l\u00f3kkal - orvosok \/ klinik\u00e1k<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Augenheilkunde_%E2%80%93_Trockene_AMD_Makuladegeneration\"><\/span>Szem\u00e9szet - Sz\u00e1raz AMD (makula degener\u00e1ci\u00f3)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Ez a klinikailag legfejlettebb \u00e9s a szab\u00e1lyoz\u00e1s szempontj\u00e1b\u00f3l legbiztons\u00e1gosabb ter\u00fclet. A k\u00e9sz\u00fcl\u00e9k&nbsp;<strong>Valeda (LumiThera)<\/strong>&nbsp;CE-tan\u00fas\u00edtv\u00e1nnyal rendelkezik, \u00e9s 2018 \u00f3ta enged\u00e9lyezett Eur\u00f3p\u00e1ban; az FDA 2024 novembere \u00f3ta enged\u00e9lyezett.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Szolg\u00e1ltat\u00f3<\/th><th>Helysz\u00edn<\/th><th>Link<\/th><\/tr><\/thead><tbody><tr><td><strong>Makula Retina K\u00f6zpont<\/strong>&nbsp;(Prof. Dr. Hakan Kaymak - a vil\u00e1g egyik legtapasztaltabb felhaszn\u00e1l\u00f3ja, aki a vil\u00e1g \u00f6sszes PBM kezel\u00e9s\u00e9nek ~10 %-j\u00e9t v\u00e9gzi.)<\/td><td>D\u00fcsseldorf<\/td><td><a href=\"https:\/\/augenchirurgie.clinic\/behandlungen\/photobiomodulation\" target=\"_blank\" rel=\"noopener\">szem\u00e9szeti seb\u00e9szet.klinika<\/a><\/td><\/tr><tr><td><strong>Witten szem\u00e9szorvos<\/strong>&nbsp;(Dr. Riha) - az egyik els\u0151 rendel\u0151 N\u00e9metorsz\u00e1gban<\/td><td>Witten \/ NRW<\/td><td><a href=\"https:\/\/www.augenarzt-witten.de\/photobiomodulation\/\" target=\"_blank\" rel=\"noopener\">augenarzt-witten.de<\/a><\/td><\/tr><tr><td><strong>Szem\u00e9sz M\u00fcnchen<\/strong>&nbsp;(Dr. Augsten)<\/td><td>M\u00fcnchen<\/td><td><a href=\"https:\/\/www.augenarzt-muc.de\/netzhaut\/behandlung\/valeda\/\" target=\"_blank\" rel=\"noopener\">szem\u00e9sz-muc.de<\/a><\/td><\/tr><tr><td><strong>Gerl \u00e9s munkat\u00e1rsai szem\u00e9szek<\/strong>&nbsp;(Valeda program)<\/td><td>M\u00fcnchen<\/td><td><a href=\"https:\/\/www.augenklinik.de\/behandlung\/valeda\" target=\"_blank\" rel=\"noopener\">eyeclinic.com<\/a><\/td><\/tr><tr><td><strong>Dr. Riha Szem\u00e9szet<\/strong><\/td><td>B\u00e9cs \/ AT<\/td><td><a href=\"https:\/\/dr-riha.com\/photobiomodulation\/\" target=\"_blank\" rel=\"noopener\">dr-riha.com<\/a><\/td><\/tr><tr><td><strong>Szem\u00e9szek Bern<\/strong>&nbsp;(CH)<\/td><td>Bern \/ CH<\/td><td><a href=\"https:\/\/www.augenaerzte-bern.ch\/leistungen\/photobiomodulation-bei-altersbedingter-makuladegeneration\/\" target=\"_blank\" rel=\"noopener\">szem\u00e9szek-bern.ch<\/a><\/td><\/tr><tr><td><strong>Berni Szem\u00e9szeti Klinika<\/strong>&nbsp;(Garweg professzor)<\/td><td>Bern \/ CH<\/td><td><a href=\"https:\/\/augenklinik-bern.ch\/fachpublikum\/amd-sprechstunde\/\" target=\"_blank\" rel=\"noopener\">szemklinika-bern.ch<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Megjegyz\u00e9s:<\/strong>\u00a0A k\u00f6lts\u00e9geket \u00e1ltal\u00e1ban nem fedezi a k\u00f6telez\u0151 eg\u00e9szs\u00e9gbiztos\u00edt\u00e1s (IGeL).<br>A LumiThera a weboldal\u00e1n keres\u0151t k\u00edn\u00e1l m\u00e1s Valeda-k\u00f6zpontok sz\u00e1m\u00e1ra.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onkologie_%E2%80%93_Orale_Mukositis_Chemo-Strahlentherapiefolge\"><\/span>Onkol\u00f3gia - Sz\u00e1jny\u00e1lkah\u00e1rtya-gyullad\u00e1s (kemoter\u00e1pia\/sug\u00e1rter\u00e1pia k\u00f6vetkezm\u00e9nye)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>A sz\u00e1jny\u00e1lkah\u00e1rtya-gyullad\u00e1s megel\u0151z\u00e9s\u00e9re \u00e9s kezel\u00e9s\u00e9re szolg\u00e1l\u00f3 PBM ir\u00e1nyelveken alapul (MASCC\/ISOO), \u00e9s egyre ink\u00e1bb be\u00e9p\u00fcl az onkol\u00f3giai t\u00e1mogat\u00f3 kezel\u00e9si programokba. Eur\u00f3pai klinikai ir\u00e1nyelvet el\u0151sz\u00f6r 2025\/2026-ban hoztak l\u00e9tre.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Szolg\u00e1ltat\u00f3<\/th><th>Hint<\/th><th>Link<\/th><\/tr><\/thead><tbody><tr><td><strong>rj-laser.com<\/strong>&nbsp;- Fog\u00e1szati l\u00e9zerter\u00e1pi\u00e1s platform a ny\u00e1lkah\u00e1rtya-gyullad\u00e1s klinikai protokolljaival<\/td><td>Szakport\u00e1l DE\/AT\/CH<\/td><td><a href=\"https:\/\/rj-laser.com\/de\/lasertherapie-mukositis-chemotherapieinduziert\" target=\"_blank\" rel=\"noopener\">rj-laser.com<\/a><\/td><\/tr><tr><td><strong>R\u00e1kinform\u00e1ci\u00f3s Szolg\u00e1lat (KID)<\/strong><\/td><td>hat\u00e1rozottan aj\u00e1nlja a PBM-et, mint a ny\u00e1lkah\u00e1rtya-gyullad\u00e1s egyik lehet\u0151s\u00e9g\u00e9t a t\u00e1mogat\u00f3 ter\u00e1pi\u00e1ban.<\/td><td><a href=\"https:\/\/www.krebsinformationsdienst.de\/fileadmin\/pdf-dateien\/informationsblaetter\/iblatt-mukositis-bei-krebs.pdf\" target=\"_blank\" rel=\"noopener\">krebsinformationsdienst.de<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>N\u00e9metorsz\u00e1gban azok a klinik\u00e1k, amelyek rutinszer\u0171en k\u00edn\u00e1lnak PBM-et a ny\u00e1lkah\u00e1rtya-gyullad\u00e1s kezel\u00e9s\u00e9re, ritk\u00e1n teszik ezt kifejezetten k\u00f6zz\u00e9 a betegoldalakon. A kezel\u00e9sre \u00e1ltal\u00e1ban a nagy onkol\u00f3giai k\u00f6zpontokban (pl. egyetemi k\u00f3rh\u00e1zakban) a fog\u00e1szati t\u00e1mogat\u00f3 ell\u00e1t\u00e1s r\u00e9szek\u00e9nt ker\u00fcl sor.<br>C\u00e9lszer\u0171 felvenni a kapcsolatot a kezel\u0151 onkol\u00f3giai k\u00f6zponttal vagy az arc- \u00e9s \u00e1llcsontseb\u00e9sszel.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dermatologie_%E2%80%93_Haut_Wundheilung_Akne_Psoriasis\"><\/span>B\u0151rgy\u00f3gy\u00e1szat - b\u0151r, sebgy\u00f3gyul\u00e1s, akne, pikkelys\u00f6m\u00f6r<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>A LED f\u00e9nyter\u00e1pi\u00e1t alkalmaz\u00f3 PBM sz\u00e1mos b\u0151rgy\u00f3gy\u00e1szati rendel\u0151ben \u00e9s eszt\u00e9tikai klinik\u00e1n bevett m\u00f3dszer.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Szolg\u00e1ltat\u00f3<\/th><th>Helysz\u00edn<\/th><th>Link<\/th><\/tr><\/thead><tbody><tr><td><strong>B\u0151rgy\u00f3gy\u00e1szat Dr. Friedl<\/strong>&nbsp;- LED f\u00e9nyter\u00e1pia (Medisol\u00ae) akne, vitiligo, pikkelys\u00f6m\u00f6r, b\u0151r\u00f6reged\u00e9s, feh\u00e9r b\u0151rr\u00e1k (PDT) kezel\u00e9s\u00e9re.<\/td><td>Ausztria<\/td><td><a href=\"https:\/\/www.dermatologie-friedl.de\/leistungen\/aesthetische-medizin\/led-lichttherapie-mit-medisol-lampe\" target=\"_blank\" rel=\"noopener\">dermatology-friedl.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Ezenk\u00edv\u00fcl N\u00e9metorsz\u00e1gban sz\u00e1mos eszt\u00e9tikai b\u0151rgy\u00f3gy\u00e1szati rendel\u0151 \u00e9s l\u00e9zerk\u00f6zpont haszn\u00e1l PBM-et (pl. Fotona rendszerekkel). Javasoljuk, hogy keressen r\u00e1 a \u201eLED f\u00e9nyter\u00e1pi\u00e1s b\u0151rgy\u00f3gy\u00e1szat\u201c vagy a \u201ePBM b\u0151rgy\u00f3gy\u00e1sz\u201c kifejez\u00e9sre egy helysz\u00ednnel egy\u00fctt.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Zahnmedizin_MKG-Chirurgie\"><\/span>Fog\u00e1szat \/ \u00e1llcsont- \u00e9s arcseb\u00e9szet<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>A PBM-et sz\u00e9les k\u00f6rben alkalmazz\u00e1k a fog\u00e1szatban, p\u00e9ld\u00e1ul temporomandibul\u00e1ris \u00edz\u00fcleti f\u00e1jdalom (CMD), posztoperat\u00edv sebgy\u00f3gyul\u00e1s, implant\u00e1tumok \u00e9s ny\u00e1lkah\u00e1rtya-gyullad\u00e1s eset\u00e9n. A fogszab\u00e1lyoz\u00f3k haszn\u00e1lj\u00e1k a&nbsp;<strong>OrthoPulse\u00ae k\u00e9sz\u00fcl\u00e9k<\/strong>&nbsp;a fogak mozg\u00e1s\u00e1nak felgyors\u00edt\u00e1s\u00e1ra (\u00f6n\u00e1ll\u00f3 alkalmaz\u00e1s, kb. 600 \u20ac).<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Szolg\u00e1ltat\u00f3 \/ Port\u00e1l<\/th><th>Hint<\/th><th>Link<\/th><\/tr><\/thead><tbody><tr><td><strong>ZWP Online<\/strong>&nbsp;- A KFO-PBM \u00e1ttekint\u00e9se<\/td><td>Szakmai port\u00e1l<\/td><td><a href=\"https:\/\/www.zwp-online.info\/zwpnews\/wirtschaft-und-recht\/recht\/photobiomodulation-in-der-kieferorthopadie\" target=\"_blank\" rel=\"noopener\">zwp-online.info<\/a><\/td><\/tr><tr><td><strong>Fotona l\u00e9zerrendszerek<\/strong>&nbsp;(Keresked\u0151\/klinika keres\u00e9s lehets\u00e9ges)<\/td><td>Fog\u00e1szati \u00e9s orvosi PBM, LightWalker<\/td><td><a href=\"https:\/\/www.fotona.com\/de\/treatments\/6496\/photobiomodulation-und-schmerzbehandlung\/\" target=\"_blank\" rel=\"noopener\">fotona.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Neurologie_Psychiatrie_%E2%80%93_Alzheimer_TBI_Depression_fruhe_Phase\"><\/span>Neurol\u00f3gia \/ Pszichi\u00e1tria - Alzheimer-k\u00f3r, TBI, depresszi\u00f3 (korai f\u00e1zis)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Ezen a ter\u00fcleten m\u00e9g folynak a klinikai vizsg\u00e1latok. N\u00e9metorsz\u00e1gban m\u00e9g mindig ritk\u00e1k a rendszeresen enged\u00e9lyezett betegell\u00e1t\u00e1sok; az els\u0151 k\u00f6zpontok \u00e9s tanulm\u00e1nyok azonban m\u00e1r l\u00e9teznek.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Szolg\u00e1ltat\u00f3 \/ Port\u00e1l<\/th><th>Hint<\/th><th>Link<\/th><\/tr><\/thead><tbody><tr><td><strong>PBM-Photobiomodulation.eu<\/strong>&nbsp;- Eur\u00f3pai inform\u00e1ci\u00f3s port\u00e1l gyakorlati \u00e1ttekint\u00e9ssel<\/td><td>DACH r\u00e9gi\u00f3<\/td><td><a href=\"https:\/\/pbm-photobiomodulation.eu\/PBM\" target=\"_blank\" rel=\"noopener\">pbm-photobiomodulation.eu<\/a><\/td><\/tr><tr><td><strong>Neurofeedback Luxemburg<\/strong>&nbsp;- t\u00e1j\u00e9koztat a neurol\u00f3giai PBM alkalmaz\u00e1sokr\u00f3l<\/td><td>LU\/DACH<\/td><td><a href=\"https:\/\/neurofeedback-luxembourg.com\/de\/photobiomodulation-ein-umfassender-leitfaden-fur-lichttherapievorteile\/\" target=\"_blank\" rel=\"noopener\">neurofeedback-luxembourg.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Allgemeine_Suchwerkzeuge\"><\/span>\u00c1ltal\u00e1nos keres\u0151eszk\u00f6z\u00f6k<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A gy\u00e1rt\u00f3 LumiThera a weboldal\u00e1n k\u00edn\u00e1l egy\u00a0<strong>Helysz\u00ednkeres\u00e9s<\/strong>\u00a0Valeda gyakorlatok:\u00a0<a href=\"https:\/\/www.lumithera.com\/\" target=\"_blank\" rel=\"noopener\">lumithera.com<\/a><\/li>\n\n\n\n<li>A port\u00e1l\u00a0<strong>pbm-photobiomodulation.eu<\/strong>\u00a0felsorolja az eur\u00f3pai gyakorlatokat<\/li>\n\n\n\n<li>A\u00a0<strong>L\u00e9zerter\u00e1pi\u00e1s Vil\u00e1gsz\u00f6vets\u00e9g (WALT)<\/strong>\u00a0glob\u00e1lis terapeutakeres\u00e9st k\u00edn\u00e1l<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Fontos megjegyz\u00e9s:<\/strong>\u00a0N\u00e9metorsz\u00e1gban a legt\u00f6bb PBM-indik\u00e1ci\u00f3 eset\u00e9ben (n\u00e9h\u00e1ny k\u00f6zpontban a szupport\u00edv onkol\u00f3gia kiv\u00e9tel\u00e9vel) m\u00e9g nem szab\u00e1lyozz\u00e1k a k\u00f6telez\u0151 eg\u00e9szs\u00e9gbiztos\u00edt\u00e1si p\u00e9nzt\u00e1rak \u00e1ltali k\u00f6lts\u00e9gfedezetet.<br>A PBM-et t\u00falnyom\u00f3r\u00e9szt a k\u00f6vetkez\u0151k\u00e9nt haszn\u00e1lj\u00e1k\u00a0<strong>IGeL szolg\u00e1ltat\u00e1s<\/strong>\u00a0mag\u00e1nc\u00e9lra sz\u00e1ml\u00e1zott.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><em>A dokumentum a PubMed, PMC, Frontiers, MDPI, Springer \u00e9s Nature szakirodalm\u00e1n alapul a 2019 \u00e9s 2026. 02. 02. k\u00f6z\u00f6tti id\u0151szakban. <\/em><br>Megjelen\u00edtve <em>A param\u00e9terek a klinikai vizsg\u00e1latokb\u00f3l \u00e9s a WALT\/MASCC aj\u00e1nl\u00e1saib\u00f3l sz\u00e1rmaznak.<\/em><\/p>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>Minden tartalom lelkiismeretesen kutatott, \u00e9s a jelenlegi (02.2026) k\u00f6zz\u00e9tett ismeretanyagot t\u00fckr\u00f6zi. Kiz\u00e1r\u00f3lag t\u00e1j\u00e9koztat\u00f3 jelleg\u0171, \u00e9s nem helyettes\u00edti a szakszer\u0171 orvosi konzult\u00e1ci\u00f3t.<br><br>A kapcsol\u00f3d\u00f3 tanulm\u00e1nyok tov\u00e1bbi orvosi \u00e9s tudom\u00e1nyos inform\u00e1ci\u00f3kkal l\u00e1tj\u00e1k el a szakembert.<\/p>\n<\/blockquote>","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Olvas\u00e1si id\u0151<\/span> <span class=\"rt-time\"> 12<\/span> <span class=\"rt-label rt-postfix\">percek<\/span><\/span>Umfassende Studien\u00fcbersicht 2023\u20132025 Einleitung Photobiomodulation (PBM), auch bekannt als Low-Level-Lasertherapie (LLLT), ist eine nicht-invasive therapeutische Methode, die Licht bestimmter Wellenl\u00e4ngen nutzt, um biologische Prozesse in lebendem Gewebe zu stimulieren.Prim\u00e4rer Mechanismus ist die Absorption von Photonen durch den mitochondrialen Photoakzeptor Cytochrom-c-Oxidase (CCO), was die ATP-Synthese steigert, reaktive Sauerstoffspezies moduliert und eine Kaskade zellul\u00e4rer Regenerationsprozesse anst\u00f6\u00dft. Das&hellip;&nbsp;<a href=\"https:\/\/csiag.de\/hu\/blog\/2026\/02\/18\/photobiomodulation-pbm\/\" rel=\"bookmark\">Olvass tov\u00e1bb \"<span class=\"screen-reader-text\">Fotobiomodul\u00e1ci\u00f3 (PBM)<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[1078,354],"tags":[],"class_list":["post-12784","post","type-post","status-publish","format-standard","hentry","category-medizin","category-medizin-gesundheit"],"modified_by":"Achim Goerner","_links":{"self":[{"href":"https:\/\/csiag.de\/hu\/wp-json\/wp\/v2\/posts\/12784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/csiag.de\/hu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csiag.de\/hu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csiag.de\/hu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/csiag.de\/hu\/wp-json\/wp\/v2\/comments?post=12784"}],"version-history":[{"count":1,"href":"https:\/\/csiag.de\/hu\/wp-json\/wp\/v2\/posts\/12784\/revisions"}],"predecessor-version":[{"id":13627,"href":"https:\/\/csiag.de\/hu\/wp-json\/wp\/v2\/posts\/12784\/revisions\/13627"}],"wp:attachment":[{"href":"https:\/\/csiag.de\/hu\/wp-json\/wp\/v2\/media?parent=12784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csiag.de\/hu\/wp-json\/wp\/v2\/categories?post=12784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csiag.de\/hu\/wp-json\/wp\/v2\/tags?post=12784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}